Investor Update: Faron Pharma applies to list on Nasdaq First North

Headlines from the Proactive UK newsroom.

Finland-based Faron Pharmaceuticals (LON:FARN) is going home and has applied to list on Nasdaq First North Growth Market, a multilateral trading facility in Helsinki. Trading is set to start on 3 December.

Oriole Resources (LON:ORR) has converted its interest in one of its Turkish assets to a 1.2% post-tax royalty. Oriole says the move will make it a valuable and potentially saleable asset.

Maxcyte (LON:MXCT) and oncology group Vor Biopharma have signed a clinical and commercial license agreement. Vor will use MaxCyte's technology to produce engineered stem cells. 

Salt Lake Potash (LON:SO4) has inked a milestone native title agreement for its flagship Lake Way project in Western Australia. The agreement paves the way for the development to get underway.

Centrica (LON:CNA) continues to bleed energy supply customers, though the British gas owner says the rate of attrition is slowing. A net 107,000 switched off in the latest few months, though guidance on earnings, cash flow and net debt for 2019 is unchanged. 

William Hill (LON:WMH) has closed 700 shops to offset the impact of the reduction of the fixed odds betting machines stake to £2. Good online growth is keeping the bookie on track even so with net revenue up 1% in the latest four weeks. 

Royal Mail’s (LON:RMG) letter business is continuing to decline and will fall further despite the boost from the general election. Half year operating profits at the postie fell 13% even though revenues rose.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Faron Pharmaceuticals Ltd named herein, including the promotion by the Company of Faron Pharmaceuticals Ltd in any Content on the Site, the...


Oracle Power Shareholder Q&A

Oracle Power's (LON:ORCP) CEO Naheed Memon takes questions from the company's shareholders delivered by Proactive London's Katie Pilbeam.  Memon addresses queries on the Thar Block VI Project in terms of key decision makers and government agencies in Pakistan.  As well as the...

19 minutes ago

2 min read